054 Treatment with ixekizumab over 60 weeks provides...

054 Treatment with ixekizumab over 60 weeks provides sustained improvements in health-related quality of life: Results from UNCOVER-1, a randomized phase 3 trial

Langley, R., Feldman, S., Paul, C., Gordon, K., Strand, V., Toth, D., Warren, R.B., Burge, R., Zhu, B., Reich, K.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
136
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2016.06.071
Date:
September, 2016
File:
PDF, 57 KB
english, 2016
Conversion to is in progress
Conversion to is failed